medigraphic.com
ISSN 0016-3813 (Impreso)

2009, Número 5

<< Anterior Siguiente >>

Gac Med Mex 2009; 145 (5)


Manejo endovascular de la ateroesclerosis carotídea Parte II. Criterios terapéuticos actuales y limitaciones

Santos-Franco JA, Zenteno-Castellanos MA, Jaramillo-Magaña JJ, Vega-Montesinos S, Lee-Aguirre Á

Idioma: Español
Referencias bibliográficas: 63
Paginas: 415-425
Archivo PDF: 192.92 Kb.


RESUMEN

Durante muchos años se ha considerado a la endarterectomía carotídea como el estándar de oro para el manejo de la aterosclerosis carotídea sintomática, lo que promovió el abuso de la técnica, mientras que se dejó a la angioplastia carotídea como una técnica alternativa relegada a los casos con riesgo quirúrgico alto. Diversos estudios ya han demostrado que la eficacia de la angioplastia carotídea es igual a la endarterectomía incluso con ciertas ventajas destacables: carece de la necesidad de anestesia general, ofrece acceso a toda la extensión de la arteria carótida y de la circulación intracraneal, y presenta menor frecuencia de complicaciones. En muchas publicaciones se ha demostrado que el número de complicaciones se equiparan o son inferiores a la cirugía. En este artículo, además de analizar los estudios que comparan a la endarterectomía con la angioplastia carotídea, evaluamos los criterios endovasculares actuales del manejo de la aterosclerosis carotídea, así como sus beneficios y limitaciones.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kerber CW, Cromwell LD, Loehden OL. Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. AJNR Am J Neuroradiol 1980;1:348-349.

  2. Theron J, Raymond J, Casasco A, Courtheoux F. Percutaneous angioplasty of atherosclerotic and postsurgical stenosis of carotid arteries. AJNR Am J Neuroradiol 1987;8:495-500.

  3. Kachel R. Results of balloon angioplasty in the carotid arteries. J Endovasc Surg 1996;3:22-30.

  4. Roubin GS, Iyer S, Halkin A, Vitek J, Brennan C. Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. Circulation 2006;113:2021-2030.

  5. Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. AHA Scientific statement: supplement to the guidelines for the management of transient ischemic attacks: a statement from the ad hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke 1999;30:2502-2511.

  6. Eliasziw M, Smith RF, Singh N, Holdsworth DW, Fox AJ, Barnett HJ. Further comments on the measurement of carotid stenosis from angiograms. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Stroke 1994;25(12):2445-2449.

  7. Rothwell PM, Gutnikov SA, Warlow CP. Reanalysis of the final results of the European Carotid Surgery Trial. Stroke 2003;34:514-523.

  8. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with highgrade carotid stenosis. N Engl J Med 1991;325:445-453.

  9. MRC European carotid Surgery Trialist. Randomised trial of endarterectomy for recently symptomatic carptid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-1387.

  10. Côté R, Battista RN, Abrahamowicz M, Langlois Y, Bourque F, Mackey A. Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group. Ann Intern Med 1995;123:649-655.

  11. The European carotid Surgery Trialist Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995;345:209-212.

  12. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis, JAMA 1995;273:1421-1428.

  13. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-1502.

  14. Nicolaides AN, Kakkos SK, Griffin M, Sabetai M, Dhanjil S, Tegos T, et al. Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS Study Eur J Vasc Endovasc Surg 2005;30:275-284.

  15. Spence JD, Tamayo A, Lownie SP, Ng WP, Ferguson GG. Absence of microemboli on transcranial doppler identifies low-risk patients with a symptomatic carotid stenosis. Stroke 2005;36:2373-2378.

  16. Touzé E, Toussaint JF, Coste J, Schmitt E, Bonneville F, Vandermarcq P, et al. HIgh-Resolution magnetic resonance Imaging in atherosclerotic Stenosis of the Carotid Artery (HIRISC) Study Group. Reproducibility of highresolution MRI for the identification and the quantification of carotid atherosclerotic plaque components: consequences for prognosis studies and therapeutic trials. Stroke 2007;38:1812-1819.

  17. Silvestrini M, Vernieri F, Pasqualetti P, Matteis M, Passarelli F, Troisi E, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000;283:2122-2127.

  18. Rothwell PM, Gibson R, Warlow CP. Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. On behalf of the European Carotid Surgery Trialists’ Collaborative Group. Stroke 2000;31:615-621.

  19. Mas J. Internal carotid artery revascularization. Rev Esp Cardiol 2007;60:861-871.

  20. Nighoghossian N, Derex L, Douek P. The vulnerable carotid artery plaque: current imaging methods and new perspectives. Stroke 2005;36:2764-2772.

  21. Dhume AS, Soundararajan K, Hunter WJ 3rd, Agrawal DK. Comparison of vascular smooth muscle cell apoptosis and fibrous cap morphology in symptomatic and asymptomatic carotid artery disease. Ann Vasc Surg 2003;17:1-8.

  22. Nandalur KR, Baskurt E, Hagspiel KD, Phillips CD, Kramer CM. Calcified carotid atherosclerotic plaque is associated less with ischemic symptoms than is noncalcified plaque on MDCT. AJR Am J Roentgenol 2005;184:295-298.

  23. Carr S, Farb A, Pearce WH, Virmani R, Yao JS. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 1996;23:755-65; discussion 765-766.

  24. Winslow CM, Solomon DH, Chassin MR, Kosecoff J, Merrick NJ, Brook RH. The appropiateness of carotid endarterectomy. N Engl J Med 1988;318:721-727.

  25. Wemberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the medicare population: trial hospitals, volume, and patients characteristics. JAMA 1998;279:1278-1281.

  26. Samuelson RM, Yamamoto J, Levy EI, Siddiqui AH, Hopkins LN. The argument to support broader application of extracranial carotid artery stent technology. Circulation 2007;116:1602-1610.

  27. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Lancet 2001;357:1729-1737.

  28. McCabe DJ, Pereira AC, Clifton A, Bland JM, Brown MM. CAVATAS Investigators. Restenosis after carotid angioplasty, stenting, or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS). Stroke 2005;36:281-286.

  29. Kasner SE, Jeffrey Saver J, Levine SR. Stroke prevention. Carotid artery disease: endarterectomy and angioplasty/stenting. Medscape Neurology & Neurosurgery, Conference Report-26th Annual International Stroke Conference. Disponible en http://www.medscape.com/viewarticle/408377_4

  30. CaRESS Steering Committee, Carotid Revasculaiztion Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg 2005;42:213-219.

  31. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected carotid-artery stenting versus endarterectomy in high risk patients. N Engl J Med 2004;351:1493-1501.

  32. SPACE Collaborative Group, Ringleb PA, Allenberg J, Brückmann H, Eckstein HH, Fraedrich G, et al. 30 day results from the SPACE trial of stentprotected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006;368:1239-1247.

  33. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, et al. EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660-1671.

  34. Weisz G. Distal protection devices improve the safety of carotid artery stenting. Analysis of over 1350 procedures. Circulation 2003;108:IV-605.

  35. Zahn R, Mark B, Niedermaier N, Zeymer U, Limbourg P, Ischinger T, et al. Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Embolic protection devices for carotid artery stenting: better results than stenting without protection? Eur Heart J 2004;25:1550-1558.

  36. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001;103:163-182.

  37. Biller J, Feinberg WM, Castaldo JE, Withemore AD, Harbaugh RE, Dempsey RJ, et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1998;29:554-562.

  38. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339:1415-1425.

  39. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-924.

  40. Alamowitch S, Eliasziw M, Algra A, Meldrum H, Barnett HJ. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet 2001;357:1154-1160.

  41. Goldstein LB, McCrory DC, Landsman PB, Samsa GP, Ancukiewicz M, Oddone EZ, Matchar DB. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsolateral symptoms. Stroke 1994;25:1116-1121.

  42. Moore WS, Barnett HJ, Beebe HG, Bernstein EF, Brener BJ, Brott T, et al. Guidelines for Carotid Endarterectomy: A Multidisciplinary Consensus Statement From the Ad Hoc Committee, American Heart Association. Stroke 1995;26:188-201.

  43. Lopes DK, Mericle RA, Lanzino G, Wakhloo AK, Guterman LR, Hopkins LN. Stent placement for the treatment of occlusive atherosclerotic carotid artery disease in patients with concomitant coronary artery disease. J Neurosurg 2002;96:490-496.

  44. Ho DS, Wang Y, Chui M, Wang Y, Ho SL, Cheung RT. Intracarotid abciximab injection to abort impending ischemic stroke during carotid angioplasty. Cerebrovasc Dis 2001;11:300-304.

  45. Lanzino G, Mericle RA, Lopes DK, Wakhloo AK, Guterman LR, Hopkins LN. Percutaneous transluminal angioplasty and stent placement for recurrent carotid artery stenosis. J Neurosurg 1999;90:688-694.

  46. Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, Atkinson R, et al. ARCHeR Trial Collaborators. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg 2006;44:258-268.

  47. Qureshi AI, Luft AR, Sharma M, Janardhan V, Lopes DK, Khan J, et al. Frequency and determinants of postprocedural hemodynamic instability after carotid angioplasty and stenting. Stroke 1999;30:2086-2093.

  48. Wholey MH, Wholey MH. History and current status of endovascular management for the extracranial carotid and supra-aortic vessels. J Endovasc Ther 2004;11 Suppl 2:II43-II61.

  49. Mendelsohn FO, Weissman NJ, Lederman RJ, Crowley JJ, Gray JL, Phillips HR, et al. Acute hemodynamic changes during carotid artery stenting. Am J Cardiol 1998;82:1077-1081.

  50. Satler LF, Laird JR. Limiting the complications of carotid stenting. Catheter Cardiovasc Interv 2001;54:524-525.

  51. MacDonald S. Strategies for avoidance of nonembolic stroke during carotid artery stenting. J Cardiovasc Surg 2007;48:27-37.

  52. Abou-Chebl A, Yadav JS, Reginelli JP, Bajzer C, Bhatt D, Krieger DW. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: Risk factors, prevention, and treatment. J Am Coll Cardiol 2004;43:1596-1601.

  53. Meyers PM, Higashida RT, Phatouros CC, Malek AM, Lempert TE, Dowd CF, Halbach VV. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery 2000;47:335-343.

  54. Ko NU, Achrol AS, Chopra M, Saha M, Gupta D, Smith WS, et al. Cerebral blood flow changes after endovascular treatment of cerebrovascular stenoses. AJNR Am J Neuroradiol 2005;26:538-542.

  55. van Mook WN, Rennenberg RJ, Schurink GW, van Oostenbrugge RJ, Mess WH, Hofman PA, de Leeuw PW. Cerebral hyperperfusion syndrome. Lancet Neurol 2005;4:877-888.

  56. Al-Mubarak N, Roubin GS, Vitek JJ, Iyer SS, New G, Leon MB. Subarachnoidal hemorrhage following carotid stenting with the distal-balloon protection. Catheter Cardiovasc Interv 2001;54:521-523.

  57. McCabe DJ, Brown MM, Clifton A. Fatal cerebral reperfusion hemorrhage after carotid stenting. Stroke 1999;30:2483-2486.

  58. Bosiers M, Peeters P, Deloose K, Verbist J, Sievert H, Sugita J, et al. Does carotid artery stenting work on the long run: 5-year results in high-volume centers (ELOCAS Registry). J Cardiovasc Surg 2005;46:241-247.

  59. Roubin GS, New G, Iyer SS, Vitek JJ, Al-Mubarak N, Liu MW, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: 5-year prospective analysis. Circulation 2001;103:532-537.

  60. Ellozy SH, Carroccio A. Drug-eluting stents in peripheral vascular disease: eliminating restenosis. Mt Sinai J Med 2003;70:417-419.

  61. Dietz U, Dauer C, Lambertz H. Combining short stent implantation and drugeluting stenting for routine use yields a low restenosis rate. Exp Clin Cardiol 2006;11:294-297.

  62. Willfort-Ehringer A, Ahmadi R, Gschwandtner ME, Haumer M, Lang W, Minar E. Single-center experience with carotid stent restenosis. J Endovasc Ther 2002;9:299-307.

  63. Arauz A, Hoyos L, Zenteno M, Mendoza R, Alexanderson E. Carotid plaque inflammation detected by 18F-flurodeoxyglucosae-positron emission tomography. Pilot Study. Clin Neurol Neurosurg 2007;109:409-412.




2020     |     www.medigraphic.com